The official blog of the Lung Institute.

Tampa-Based Pulmonary Cellular Therapy Clinics Shows Promising Results

31 Jul 2013
| Under Press | Posted by | 0 Comments

Lung Institute Treats Over 40 Patients in Only Two Months

Tampa, FL (July 31, 2013) – State-of-the-art pulmonary cellular therapy provider, Lung Institute (LI), opened in May with the goal of providing those with debilitating lung conditions a better quality of life. That goal is quickly becoming realized.

Since the May opening, LI has treated over 40 patients with a variety of conditions ranging from chronic obstructive pulmonary disease (COPD) to pulmonary fibrosis. In a six-week follow up survey, nearly 70% of patients reported positive results.

“Considering most of our patients have been told by doctors that they have no further course of treatment, these numbers are amazing,” said Jimmy St. Louis, CEO of Lung Institute. “And this is just the beginning. With more and more patients reaching the six-week post treatment mark, we are excited to see these numbers grow.”

People from all across the nation are taking notice of the Lung Institute’s innovative procedures utilizing regenerative medicine. Their highly trained physicians have already touched the lives of many patients. The Lung Institute’s patients have come from not only from the United States, but from countries in Africa, Asia, Europe, and South America. 

About Lung Institute:

The Lung Institute is a leading medical provider of regenerative cellular therapy for lung diseases such as COPD, pulmonary fibrosis and interstitial lung disease. Founded in 2013 in Tampa, Fla., the Lung Institute currently has clinics in Tampa, Fla., Nashville, Tenn., Scottsdale, Ariz., Pittsburgh, Pa. and Dallas, Texas. For more information, please visit www.lunginstitute.com or call 888-745-6697.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.